Skip to main content

Your search for “Generic Drugs” returned 491 results

Medicare is Overpaying for Generic Drugs

December 5, 2023

Researchers from the University of California San Diego, West Health, and the University of Washington have found evidence that the private insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.

High R&D Isn’t Necessarily Why Drugs Are So Expensive

September 26, 2022

In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.

The Rising Price of Medicare Part D’s 10 Most Costly Medications

July 5, 2018

…Part D — the U.S. federal government’s primary prescription drug benefit for older citizens — rose almost one-third between 2011 and 2015, even as the number of persons using these drugs dropped by the same amount.

Potency Of Statins Linked To Muscle Side Effects

August 22, 2012

A study from the University of California, San Diego School of Medicine, published August 22 online by PLoS ONE, reports that muscle problems reported by patients taking statins were related to the strength or potency of the given cholesterol-lowering drugs.

Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies

January 31, 2023

UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.

How Decriminalizing Drugs Might Affect the Spread of HIV in Tijuana

June 9, 2016

…Diego Publications How Decriminalizing Drugs Might Affect the Spread of HIV in Tijuana Richard Branson and experts debate the losing war on drugs—and its victims—at UC San Diego event As the 1960s came to a close, Richard Nixon famously declared a “war on drugs.” They were “public enemy number one,”…

UC San Diego Biophysicists Examine Development of Antibiotic Resistance

December 5, 2013

…antibiotics and developing new drugs against bacteria already resistant to conventional drug treatments. But understanding how bacteria grow and evolve drug resistance could also help stop its spread by allowing scientists to target the process of evolution itself. “Understanding how bacteria harboring antibiotic resistance grow in the presence of antibiotics…

Researchers Develop New Tools to Optimize CHO Cell Lines for Making Biologic Drugs

April 13, 2017

…metabolic models, to optimize CHO cell production of biologic drugs in the hope of driving down their costs.

Breast Cancer Drug Beats Superbug

October 13, 2015

…and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.

Cancer Drug and Antidepressants Provide Clues for Treating Fatal Brain-Eating Amoeba Infections

September 13, 2018

…identified three new molecular drug targets in Naegleria fowleri and a number of drugs that are able to inhibit the amoeba’s growth in a laboratory dish. Several of these drugs are already approved by the U.S. Food and Drug Administration for other uses, such as antifungal agents, the breast cancer…

Category navigation with Social links